In vitro potency, pharmacokinetic profiles and pharmacological activity of optimized anti-IL-21R antibodies in a mouse model of lupus-Reference-Cited by-同舟云学术

In vitro potency, pharmacokinetic profiles and pharmacological activity of optimized anti-IL-21R antibodies in a mouse model of lupus

Published:2010-05 Issue:3 Volume:2 Page:335-346
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Vugmeyster Yulia,Guay Heath,Szklut Pamela,Qian Ming D.,Jin Macy,Widom Angela,Spaulding Vikki,Bennett Frann,Lowe Leslie,Andreyeva Tatyana,Lowe David C.,Lane Steven,Thom George,Valge-Archer Viia,Gill Davinder,Young Deborah,Bloom Laird

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.4161/mabs.2.3.11850

Reference31 articles.

1. Biologic therapies in rheumatology: lessons learned, future directions

2. Potent antibody therapeutics by design

3. Fully human antibodies from transgenic mouse and phage display platforms

4. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function

5. T Follicular Helper (TFH) Cells in Normal and Dysregulated Immune Responses

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Animal models of systemic lupus erythematosus (SLE);Dubois' Lupus Erythematosus and Related Syndromes;2025

2. Immune-Mediated Liver Effects Associated With Administration of a Human Anti-IL-21 Receptor Antibody (ATR-107) in Rats;Toxicologic Pathology;2024-07-25

3. In vivo affinity maturation of mouse B cells reprogrammed to express human antibodies;Nature Biomedical Engineering;2024-03-14

4. In vivoaffinity maturation of the HIV-1 Env-binding domain of CD4;2024-02-05

5. Monoclonal Antibodies: From Structure to Therapeutic Application;Pharmaceutical Biotechnology;2024